Paul Ratcliffe

USPTO Granted Patents = 15 (Patent Applications = 32)

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

Years Active: 2016-2024

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12110293 - Substituted triazolo quinoxaline derivatives (2024-10-08),

2. 11981677 - Further substituted triazolo quinoxaline derivatives (2024-05-14),

3. 10981918 - Further substituted triazolo quinoxaline derivatives (2021-04-20),

4. 10829480 - 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives (2020-11-10),

5. 10807989 - 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-20),

6. 10807988 - 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-20),

7. 10793556 - 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-06),

8. 10793528 - 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-06),

9. 10738015 - 1,3-diaza-spiro-[3.4]-octane derivatives (2020-08-11),

10. 10214520 - Substituted azaspiro(4.5)decane derivatives (2019-02-26),

11. 10202345 - Substituted azaspiro(4.5)decane derivatives (2019-02-12),

12. 9802947 - 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5H)-yl) derivatives II (2017-10-31),

13. 9725459 - 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I (2017-08-08),

14. 9670189 - Substituted condensed pyrimidine compounds (2017-06-06),

15. 9527832 - Substituted condensed pyrimidine compounds (2016-12-27),

Title: The Innovative Journey of Paul Ratcliffe

Introduction:

Paul Ratcliffe, a visionary inventor based in Aachen, Germany, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

Paul Ratcliffe's latest patents include a cutting-edge software application for optimizing energy consumption in smart homes and a revolutionary medical device for non-invasive monitoring of vital signs.

Career Highlights:

With a career spanning over two decades, Paul Ratcliffe has established himself as a leading figure in the tech industry. His innovative solutions have garnered international recognition and have been instrumental in shaping the future of various sectors.

Collaborations:

Throughout his career, Paul Ratcliffe has collaborated with top research institutions and leading tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion:

In conclusion, Paul Ratcliffe's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor in the tech world. His work continues to inspire and drive progress in the ever-evolving landscape of technology.

This text is generated by artificial intelligence and may not be accurate.